No heart benefit seen with fibrates [Tricor] in diabetics (reuters)
SJCRG: In a nutshell, study purports that a class of drugs called fenofibrates, who aim to to lower the blood fat triglycerides and raise good HDL cholesterol, are of little benefit. TriCor, from Abbots labs belongs to such.
Study conclusions do not seem iron clad, but raises a flag. click HERE for Reuters article.
SJRG: FDA current position on this:
“…At this time, FDA has made no new conclusions or recommendations regarding the combination use of simvastatin or other statin drugs and fenofibrate. The agency will conduct a thorough review of the primary ACCORD data as soon as they become available….” click HERE for FDA position
Categories: CHF, Diabetes, Good Cholestreol, HDL, Heart Failure, High Blood Pressure, Triglycerides, heart disease Tags: benefit, CareResourceGuide, diabetics, fibrates, heart, no, reuters, sjcrg
Caution Urged in Reducing Blood Pressure in Patients With Diabetes, Coronary Disease (ScienceDaily)
SJCRG:
Quoting:
“…recommends raising the systolic bar above 120 for blood pressure in patients with diabetes and coronary artery disease, saying that levels between 130 and 140 appear to be the most healthful…..”
CLICK HERE for link to SD article
SJCRG:
A similar warning was given for sugar levels, to see our previous Post on this Topic CLICK HERE
Categories: Alert, Blood Pressure, Diabetes, High Blood Pressure, Uncategorized, heart disease Tags: Blood Pressure, CareResourceGuide, Caution, Coronary Disease, Diabetes, Reducing, ScienceDaily, sjcrg
Categories: Acid Reflux, Blood Pressure, GERD, GastroIntestinal, High Blood Pressure, Oesophagus, cancer, heart disease Tags: Acid Reflux, Anti-Hypertensive, CareResourceGuide, Contraction, drugs, Enhance, Esophageal, GERD, medicalnewstoday, sjcrg, Some
